| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |